vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Expion360 Inc. (XPON). Click either name above to swap in a different company.

Expion360 Inc. is the larger business by last-quarter revenue ($2.2M vs $1.1M, roughly 1.9× Insight Molecular Diagnostics Inc.). Expion360 Inc. runs the higher net margin — -199.9% vs -2015.4%, a 1815.4% gap on every dollar of revenue. On growth, Expion360 Inc. posted the faster year-over-year revenue change (11.8% vs -23.4%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 51.1%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Expion360 Inc. is a provider of high-performance lithium iron phosphate (LFP) battery solutions and supporting energy storage products. Its core customer segments cover recreational vehicle owners, marine users, off-grid lifestyle enthusiasts and residential users across the U.S. market, delivering safe, durable and low-carbon energy storage options.

IMDX vs XPON — Head-to-Head

Bigger by revenue
XPON
XPON
1.9× larger
XPON
$2.2M
$1.1M
IMDX
Growing faster (revenue YoY)
XPON
XPON
+35.1% gap
XPON
11.8%
-23.4%
IMDX
Higher net margin
XPON
XPON
1815.4% more per $
XPON
-199.9%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
51.1%
XPON

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMDX
IMDX
XPON
XPON
Revenue
$1.1M
$2.2M
Net Profit
$-23.0M
$-4.4M
Gross Margin
42.5%
-14.8%
Operating Margin
-2057.5%
-234.4%
Net Margin
-2015.4%
-199.9%
Revenue YoY
-23.4%
11.8%
Net Profit YoY
31.5%
-1663.2%
EPS (diluted)
$-0.75
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
XPON
XPON
Q4 25
$1.1M
$2.2M
Q3 25
$260.0K
$2.4M
Q2 25
$518.0K
$3.0M
Q1 25
$2.1M
$2.0M
Q4 24
$1.5M
$2.0M
Q3 24
$115.0K
$1.4M
Q2 24
$104.0K
$1.3M
Q1 24
$176.0K
$971.9K
Net Profit
IMDX
IMDX
XPON
XPON
Q4 25
$-23.0M
$-4.4M
Q3 25
$-10.9M
$722.8K
Q2 25
$-9.7M
$-1.4M
Q1 25
$-6.7M
$-1.2M
Q4 24
$-33.5M
$-251.6K
Q3 24
$-13.5M
$-8.8M
Q2 24
$-4.5M
$-2.2M
Q1 24
$-9.1M
$-2.2M
Gross Margin
IMDX
IMDX
XPON
XPON
Q4 25
42.5%
-14.8%
Q3 25
53.5%
22.7%
Q2 25
67.6%
20.8%
Q1 25
62.0%
24.5%
Q4 24
40.0%
22.1%
Q3 24
43.5%
12.1%
Q2 24
48.1%
25.5%
Q1 24
25.6%
22.9%
Operating Margin
IMDX
IMDX
XPON
XPON
Q4 25
-2057.5%
-234.4%
Q3 25
-4249.2%
-125.4%
Q2 25
-1900.0%
-45.2%
Q1 25
-318.0%
-56.0%
Q4 24
-2262.9%
-59.5%
Q3 24
-11752.2%
-138.7%
Q2 24
-4453.8%
-131.4%
Q1 24
-5265.3%
-202.4%
Net Margin
IMDX
IMDX
XPON
XPON
Q4 25
-2015.4%
-199.9%
Q3 25
-4174.6%
30.2%
Q2 25
-1880.7%
-45.8%
Q1 25
-312.0%
-56.2%
Q4 24
-2255.1%
-12.7%
Q3 24
-11733.0%
-634.4%
Q2 24
-4355.8%
-173.7%
Q1 24
-5186.9%
-225.6%
EPS (diluted)
IMDX
IMDX
XPON
XPON
Q4 25
$-0.75
$-0.45
Q3 25
$-0.34
$0.10
Q2 25
$-0.30
$-0.41
Q1 25
$-0.26
$-0.37
Q4 24
$-2.19
$65.02
Q3 24
$-0.98
$-24.55
Q2 24
$-0.36
$-30.20
Q1 24
$-1.13
$-31.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
XPON
XPON
Cash + ST InvestmentsLiquidity on hand
$11.6M
$3.0M
Total DebtLower is stronger
$197.2K
Stockholders' EquityBook value
$-31.5M
$6.5M
Total Assets
$25.8M
$8.1M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
XPON
XPON
Q4 25
$11.6M
$3.0M
Q3 25
$18.7M
$4.3M
Q2 25
$24.3M
$684.9K
Q1 25
$31.0M
$1.1M
Q4 24
$8.6M
$547.6K
Q3 24
$3.4M
$3.3M
Q2 24
$9.3M
$902.3K
Q1 24
$5.6M
$2.3M
Total Debt
IMDX
IMDX
XPON
XPON
Q4 25
$197.2K
Q3 25
$205.6K
Q2 25
$213.6K
Q1 25
$221.8K
Q4 24
$230.2K
Q3 24
$239.9K
Q2 24
$247.7K
Q1 24
$255.4K
Stockholders' Equity
IMDX
IMDX
XPON
XPON
Q4 25
$-31.5M
$6.5M
Q3 25
$-9.2M
$9.0M
Q2 25
$1.1M
$2.1M
Q1 25
$10.2M
$3.2M
Q4 24
$-12.3M
$2.5M
Q3 24
$9.7M
$2.5M
Q2 24
$22.7M
$2.5M
Q1 24
$11.6M
$3.7M
Total Assets
IMDX
IMDX
XPON
XPON
Q4 25
$25.8M
$8.1M
Q3 25
$43.9M
$10.7M
Q2 25
$50.5M
$8.6M
Q1 25
$60.4M
$9.2M
Q4 24
$35.1M
$9.1M
Q3 24
$70.2M
$10.1M
Q2 24
$74.7M
$8.8M
Q1 24
$71.0M
$10.0M
Debt / Equity
IMDX
IMDX
XPON
XPON
Q4 25
0.03×
Q3 25
0.02×
Q2 25
0.10×
Q1 25
0.07×
Q4 24
0.09×
Q3 24
0.09×
Q2 24
0.10×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
XPON
XPON
Operating Cash FlowLast quarter
$-5.5M
$-2.4M
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
XPON
XPON
Q4 25
$-5.5M
$-2.4M
Q3 25
$-4.5M
$-2.1M
Q2 25
$-6.3M
$-401.0K
Q1 25
$-5.9M
$-1.2M
Q4 24
$-5.4M
$-2.9M
Q3 24
$-5.5M
$-3.2M
Q2 24
$-6.0M
$-1.7M
Q1 24
$-3.8M
$-1.7M
Free Cash Flow
IMDX
IMDX
XPON
XPON
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
Q3 24
$-5.6M
Q2 24
$-6.2M
Q1 24
$-3.9M
$-1.7M
FCF Margin
IMDX
IMDX
XPON
XPON
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
Q3 24
-4884.3%
Q2 24
-5931.7%
Q1 24
-2189.8%
-173.1%
Capex Intensity
IMDX
IMDX
XPON
XPON
Q4 25
129.9%
Q3 25
403.8%
Q2 25
67.4%
Q1 25
14.4%
Q4 24
14.4%
Q3 24
75.7%
Q2 24
183.7%
Q1 24
13.6%
1.1%
Cash Conversion
IMDX
IMDX
XPON
XPON
Q4 25
Q3 25
-2.90×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons